热门资讯> 正文

下一篇Cure GAAP每股收益为-19.65美元

2026-03-06 15:47

NextCure(NXTC) 0

NextCure press release (NXTC): FY GAAP EPS of -$19.65.
Cash, cash equivalents, and marketable securities as of December 31, 2025 were $41.8 million as compared to $68.6 million as of December 31, 2024.

More on NextCure

Seeking Alpha’s Quant Rating on NextCure
Historical earnings data for NextCure
Financial information for NextCure

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。